All In MedTech

Device Trial Radar · NCT04763018

Study of External Neuromodulation to Improve Signs and Symptoms of Dry Eye in Visual Display Terminal Users

A Randomized Sham Controlled Study of External Neuromodulation to Improve Signs and Symptoms of Dry Eye in Visual Display Terminal Users

Last checked: Nov 19, 2026Latest source record: Feb 21, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

35

Planned (sponsor's estimate)

Start

Feb 17, 2021

Primary completion

May 1, 2021

Study completion Jun 1, 2021

Sponsor

Lead sponsor
Olympic Ophthalmics, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Feb 21, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 69 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Two study arms - sham and treatment; There will be a cross over of the sham group to the treatment group at day 15.

Conditions

  • Visual Display Users With Previously Undiagnosed Dry Eye

Interventions

  • iTEAR100Device

    Neurostimulation external nasal nerve to stimulate tear production

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Meibomian Gland change in expressibilityTime frame: 14 days
  2. Corneal StainingTime frame: 14 days
  3. Basal tear outputTime frame: 14 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Fishman Vision

    Palo Alto, California · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.